201 related articles for article (PubMed ID: 8528303)
1. Denovo urothelial carcinoma of the upper and lower urinary tract in kidney--transplant patients with end-stage analgesic nephropathy.
Thon WF; Kliem V; Truss MC; Anton P; Kuczyk M; Stief CG; Brunkhorst R
World J Urol; 1995; 13(4):254-61. PubMed ID: 8528303
[TBL] [Abstract][Full Text] [Related]
2. High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation.
Kliem V; Thon W; Krautzig S; Kolditz M; Behrend M; Pichlmayr R; Koch KM; Frei U; Brunkhorst R
Transpl Int; 1996; 9(3):231-5. PubMed ID: 8723192
[TBL] [Abstract][Full Text] [Related]
3. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic nephroureterectomy to exclude upper urinary tract malignancy associated with analgesic nephropathy.
Doehn C; Fornara P; Fricke L; Jocham D
J Endourol; 2001 Oct; 15(8):809-14. PubMed ID: 11724120
[TBL] [Abstract][Full Text] [Related]
5. High frequency of urothelial cancers in patients with kidney transplantations for end-stage analgesic nephropathy.
Bokemeyer C; Thon WF; Brunkhorst T; Kuczyk MA; Pichlmayr R; Kleim V
Eur J Cancer; 1996 Jan; 32A(1):175-6. PubMed ID: 8695229
[No Abstract] [Full Text] [Related]
6. The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure.
McCredie M; Stewart JH; Mathew TH; Disney AP; Ford JM
Clin Nephrol; 1989 Jan; 31(1):35-9. PubMed ID: 2783667
[TBL] [Abstract][Full Text] [Related]
7. [Urologic malignancies in renal transplant candidates and recipients].
Kleinclauss F; Thuret R; Murez T; Timsit MO
Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
[TBL] [Abstract][Full Text] [Related]
8. [Urothelial carcinoma in kidney transplant recipients and candidates: The French guidelines from CTAFU].
Boissier R; Thuret R; Prudhomme T; Verhoest G; Bessede T; Branchereau J; Goujon A; Drouin S; Boutin JM; Neuzillet Y; Roupret M; Méjean A; Timsit MO
Prog Urol; 2021 Jan; 31(1):31-38. PubMed ID: 33423744
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
Boissier R; Hevia V; Bruins HM; Budde K; Figueiredo A; Lledó-García E; Olsburgh J; Regele H; Taylor CF; Zakri RH; Yuan CY; Breda A
Eur Urol; 2018 Jan; 73(1):94-108. PubMed ID: 28803033
[TBL] [Abstract][Full Text] [Related]
10. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
[TBL] [Abstract][Full Text] [Related]
11. Analgesic nephropathy and renal transplantation.
Schwarz A; Offermann G; Keller F
Nephrol Dial Transplant; 1992; 7(5):427-32. PubMed ID: 1321379
[TBL] [Abstract][Full Text] [Related]
12. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
[TBL] [Abstract][Full Text] [Related]
13. Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy.
Blohmé I; Johansson S
Kidney Int; 1981 Nov; 20(5):671-5. PubMed ID: 7045494
[TBL] [Abstract][Full Text] [Related]
14. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
[TBL] [Abstract][Full Text] [Related]
15. Significance of atypical urinary cytology in the evaluation of patients with end-stage renal disease for kidney transplantation - a retrospective study.
Law J; Ali O; Dobrin A; Brar H; Luke PP; Sener A
Transpl Int; 2019 Oct; 32(10):1085-1094. PubMed ID: 31100185
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and mechanistic basis of analgesic-associated nephropathy.
Gregg NJ; Elseviers MM; De Broe ME; Bach PH
Toxicol Lett; 1989 Mar; 46(1-3):141-51. PubMed ID: 2650021
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
Liu YQ; Lu J; Zhao L; Hou XF; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):605-10. PubMed ID: 26284394
[TBL] [Abstract][Full Text] [Related]
18. Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.
Wang LJ; Lee SY; Teh BT; Chuang CK; Nortier J
Biomed Res Int; 2014; 2014():989458. PubMed ID: 25177705
[TBL] [Abstract][Full Text] [Related]
19. [Phenacetin abuse. VII: Urinary tract tumors in dialysis patients and patients with kidney grafts].
Mihatsch MJ; Brunner FP; Korteweg E; Rist M; Dalquen P; Thiel G
Schweiz Med Wochenschr; 1982 Oct; 112(42):1468-72. PubMed ID: 6755696
[TBL] [Abstract][Full Text] [Related]
20. Analgesic nephropathy as a cause of end-stage renal disease in a 55 year-old Nigerian.
Okafor UH; Unuigbe EI; Onwuchekwa AC; Emem-Chioma P
Niger J Clin Pract; 2012; 15(2):231-4. PubMed ID: 22718180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
